Literature DB >> 24804740

FDA clearance paves way for computerized ADHD monitoring.

Elie Dolgin.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24804740     DOI: 10.1038/nm0514-454

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.

Authors:  M H Teicher; C M Anderson; A Polcari; C A Glod; L C Maas; P F Renshaw
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  Objective measurement of hyperactivity and attentional problems in ADHD.

Authors:  M H Teicher; Y Ito; C A Glod; N I Barber
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-03       Impact factor: 8.829

  2 in total
  4 in total

1.  The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures.

Authors:  Stephen V Faraone; Jeffrey H Newcorn; Kevin M Antshel; Lenard Adler; Kurt Roots; Monika Heller
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-04-22       Impact factor: 2.576

2.  Biomarkers in Child Mental Health: a bio-psycho-social perspective is needed.

Authors:  Aribert Rothenberger; Luis Augusto Rhode; Lillian Geza Rothenberger
Journal:  Behav Brain Funct       Date:  2015-09-30       Impact factor: 3.759

3.  The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study.

Authors:  Rajna Knez; Dejan Stevanovic; Salmir Nasic; Ana Doric; Elisabet Wentz
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-06       Impact factor: 2.570

4.  ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.

Authors:  Dejan Stevanovic; Elisabet Wentz; Salmir Nasic; Rajna Knez
Journal:  BMC Psychiatry       Date:  2022-04-20       Impact factor: 4.144

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.